Article
Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study.
European journal of pharmacology - 15 Apr 2015
van Rooij Kim, Poels Saskia, Worst Petra, Bloemers Jos, Koppeschaar Hans, Goldstein Andrew, Olivier Berend, Tuiten Adriaan
Abstract excerpt
Selective serotonin reuptake inhibitors (SSRIs) are known to cause sexual dysfunction, such as decreased sexual motivation, desire, arousal, and orgasm difficulties. These SSRI-induced sexual complaints have a high prevalence rate, while there is no approved pharmacological treatment for SSRI-induced sexual dysfunction. It is hypothesized that a polymorphisms in the androgen receptor gene, encoded by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
